Compare

    Two terms, side by side

    Pick any two terms to see definitions, context, pitfalls, and sources in parallel.

    Curated comparison tables

    In-depth, attribute-by-attribute tables for the most common MedTech term pairs. Each row is sourced from the linked term pages.

    Quality & Risk

    Complaint Handling

    In one line
    Process for receiving, evaluating, and responding to device complaints.
    Definition
    Per 21 CFR 820.198, manufacturers must maintain procedures for receiving, reviewing, and evaluating complaints, with timely investigation and - when reportable - submission to FDA under 21 CFR Part 803. A complaint is any communication alleging deficiencies in identity, quality, durability, reliability, usability, safety, effectiveness or performance of a device after release. Each one must be evaluated for whether it is a reportable event, investigated unless a documented rationale says otherwise, and trended. Under the QMSR, complaint requirements sit in ISO 13485 clause 8.2.2 plus FDA-specific record content kept in 21 CFR 820.35.
    Why it matters
    Complaint handling is the entry point for the post-market feedback loop, feeding CAPA, vigilance, and risk management updates.
    Common pitfalls
    • •Failure to define clear criteria for what constitutes a complaint can lead to underreporting or misclassification.
    • •Inadequate investigation of complaints can result in recurring issues and potential harm to patients.
    • •Delay in reporting reportable events to regulatory authorities can lead to severe non-compliance penalties.
    • •Treating complaints solely as customer service issues rather than critical quality data can prevent effective corrective actions.
    • •Insufficient documentation of complaint investigations and resolutions can lead to audit findings and regulatory scrutiny.
    Open full page
    Select term B to compare.

    Why compare MedTech terms side by side?

    MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

    Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

    Common comparison patterns

    How to use this tool

    Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

    MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.